業績

HOME > 業績 > 原著
  • 原著 Small Intestinal Bacterial Overgrowth Is a Predictor of Overt Hepatic Encephalopathy in Patients with Liver Cirrhosis
    Sakamaki A, Yokoyama K, Yamazaki H, Wakabayashi T, Kojima Y, Tominaga K, Tsuchiya A, Kamimura K, Yokoyama J, Terai S.
    J Clin Med. 2025 Feb 23;14(5):1491. doi: 10.3390/jcm14051491.
  • 原著 節酒はdysbiosisを改善し、その評価に%CDTは有用である
    若林拓哉, 坂牧僚, 山崎華子, 五十嵐崇徳, 阿部寛幸, 林和直, 寺井崇二
    アルコールと医学生物学 44巻 76-77
  • 原著 Targeted animal models for preclinical assessment of cellular and gene therapies in pancreatic and liver diseases: regulatory and practical insights
    Wang H, Ciccocioppo R, Terai S, Shoeibi S, Carnevale G, De Marchi G, Tsuchiya A, Ishii S, Tonouchi T, Furuyama K, Yang Y, Mito M, Abe H, Di Tinco R, Cardinale V.
    Cytotherapy. 2024 Nov 19:S1465-3249(24)00934-4. doi: 10.1016/j.jcyt.2024.11.008. Online ahead of print.
  • 原著 Safety of edoxaban for delayed bleeding in gastrointestinal endoscopic procedures with a high risk of bleeding
    Mizuno KI, Yokoyama J, Shibata O, Kojima Y, Kawata Y, Takahashi K, Tominaga K, Satoshi I, Kazunao H, Terai S.
    DEN Open. 2024 Oct 3;5(1):e70018. doi: 10.1002/deo2.70018. eCollection 2025 Apr.
  • 原著 Esophageal varices as an independent predictor of fatal outcomes after balloon-occluded retrograde transvenous obliteration in patients with hepatic encephalopathy
    Iwasaki S, Uojima H, Sakita S, Masuda S, Kubota K, Fujikawa T, Okubo T, Setsu T, Itokawa N, Furuichi Y, Arase Y, Tukiyama T, Fujii K, Hidaka H, Atsukawa M, Kagawa T, Kako M, Terai S, Kusano C.
    Dig Dis. 2024;42(6):583-592. doi: 10.1159/000541660. Epub 2024 Sep 30.
  • 原著 Achalasia phenotypes and prediction of peroral endoscopic myotomy outcomes using machine learning
    Takahashi K, Sato H, Shimamura Y, Abe H, Shiwaku H, Shiota J, Sato C, Hamada K, Ominami M, Hata Y, Fukuda H, Ogawa R, Nakamura J, Tatsuta T, Ikebuchi Y, Yokomichi H, Terai S, Inoue H.
    Dig Endosc. 2024 Jul;36(7):789-800. doi: 10.1111/den.14714. Epub 2023 Dec 1.
  • 原著 Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease Model
    Yakubo S, Abe H, Li Y, Kudo M, Kimura A, Wakabayashi T, Watanabe Y, Kimura N, Setsu T, Yokoo T, Sakamaki A, Kamimura H, Tsuchiya A, Kamimura K, Terai S.
    Diseases. 2024 Dec 4;12(12):317. doi: 10.3390/diseases12120317.
  • 原著 PCPE-1, a brown adipose tissue-derived cytokine, promotes obesity-induced liver fibrosis
    Hsiao YT, Yoshida Y, Okuda S, Abe M, Mizuno S, Takahashi S, Nakagami H, Morishita R, Kamimura K, Terai S, Aung TM, Li J, Furihata T, Tang JY, Walsh K, Ishigami A, Minamino T, Shimizu I.
    EMBO J. 2024 Nov;43(21):4846-4869. doi: 10.1038/s44318-024-00196-0. Epub 2024 Aug 19.
  • 原著 Fibulin-4 as a potential extracellular vesicle marker of fibrosis in patients with cirrhosis
    Kumagai M, Tsuchiya A, Yang Y, Takeda N, Natsui K, Natusi Y, Tomiyoshi K, Yamazaki F, Koseki Y, Shinchi H, Imawaka N, Ukekawa R, Nishibu T, Abe H, Sasaki T, Ueda K, Terai S.
    FEBS Open Bio. 2024 Aug;14(8):1264-1276. doi: 10.1002/2211-5463.13842. Epub 2024 Jun 9.
  • 原著 Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease
    Nagayama I, Kamimura K, Owaki T, Ko M, Nagoya T, Tanaka Y, Ohkoshi M, Setsu T, Sakamaki A, Yokoo T, Kamimura H, Terai S.
    Hepatol Int. 2024 Feb;18(1):155-167. doi: 10.1007/s12072-023-10601-1. Epub 2023 Oct 21.